NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation-Reference-Cited by-同舟云学术

NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation

Published:2016-09-08 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

García-Carpizo Verónica,Sarmentero Jacinto,Han Bomie,Graña Osvaldo,Ruiz-Llorente Sergio,Pisano David G.,Serrano Manuel,Brooks Harold B.,Campbell Robert M.,Barrero Maria J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep32952.pdf

Reference58 articles.

1. Morishita, M. & Di Luccio, E. Cancers and the NSD family of histone lysine methyltransferases. Biochim. Biophys. Acta - Rev. Cancer 1816, 158–163 (2011).

2. Stec, I. et al. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum. Mol. Genet. 7, 1071–82 (1998).

3. Chesi, M. et al. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92, 3025–34 (1998).

4. Jaffe, J. D. et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat. Genet. 45, 1386–91 (2013).

5. Oyer, J. A. et al. Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies. Leukemia 28, 198–201 (2014).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in targeting histone H3 lysine 36 methyltransferases for cancer therapy;European Journal of Medicinal Chemistry;2024-08

2. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer;Frontiers in Pharmacology;2024-04-12

3. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer;Cancer Letters;2024-04

4. The expression and regulation of the nuclear receptor-binding SET domain protein 2 in parotid carcinoma;2024-03-14

5. Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs;European Journal of Medicinal Chemistry;2024-03